Aradigm Corporation

(ARDM) Trade

By |

Profile

Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The company has respiratory inhalation products in preclinical and clinical development for the treatment of cystic fibrosis, bronchiectasis, biodefense, and tobacco smoking cessation. It derives revenue from the grants, collaboration agreements, and feasibility studies.

Contact Information

Website: www.aradigm.com
Email: investor@aradigm.com
Main Phone: +1 510 265-9000
Address: 3929 Point Eden Way
State: CA
City / Town: Hayward
Country: USA
Postal Code: 94545

Issuer Information

Exchange: NSC
CEO: John M. Siebert
Employees: 23
NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing(334510)
$ 0.51 $ -0.03 (-5.56%)
Last Price 0.51 Change $ -0.03 Change % -5.56 Tick N/A
Bid 0.51 Bid Size 7,300.00 Ask 0.51 Ask Size 100.00
Open 0.54 High 0.55 Low 0.51 Prev Close 0.54
Last Trade Volume 79,789 52 Wk Hi 7.35 52 Wk Low 0.45
Market Cap 7.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 15,219,793.00 EPS (TTM) -1.09 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 2
Number of Buys 0 0
Number of Sells 0 2
Net Activity 0 -19276
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Juergen Kurt Froehlich 1,000
Juergen Kurt Froehlich 1,000
Juergen Kurt Froehlich 1,000
Juergen Kurt Froehlich 1,000
Virgil D. Thompson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 10 10 10 10
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 09/28/17 09/28/17 09/28/17 09/28/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3